Clade specific neutralising vaccines for HIV: an appropriate target?

Area of Science:

• Virology
• Immunology
• Vaccine Development

Background:

• Human immunodeficiency virus (HIV) exhibits significant genetic diversity across different clades.
• The concept of clade-specific vaccines has been proposed to simplify HIV vaccine design.
• All HIV strains utilize conserved cellular receptors (CD4, CCR5, CXCR4) for entry.

Purpose of the Study:

• To review evidence supporting clade-specific vaccine strategies for inducing neutralizing antibodies.
• To analyze lessons learned from natural HIV infection regarding antibody responses.
• To evaluate the potential for clade-specific versus clade-generic vaccine approaches.

Main Methods:

• Review of existing scientific literature on HIV neutralization.
• Analysis of data from natural human HIV infections.
• Examination of human neutralizing monoclonal antibodies and their targets.

Main Results:

• The vast majority of studies indicate HIV-1 neutralization is not clade-specific.
• Potent sera and neutralizing monoclonal antibodies show broad activity against various clades.
• Effective antibodies target conserved functional regions involved in receptor binding and fusion.

Conclusions:

• Clade-specific and clade-generic vaccine strategies likely converge on conserved viral envelope structures.
• Focusing on conserved regions is crucial for developing broadly effective HIV vaccines.
• Further research is needed to determine if 'transmitting phenotypes' can simplify clade-generic vaccine design.